Windlas Biotech Limited, a active public limited company, was established on 19 February 2001 in Dehradun, Uttarakhand, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L74899UR2001PLC033407. Registered under ROC Roc Uttarakhand. it is listed on BSE: 543329 and NSE: WINDLAS. It has an authorized capital of ₹77.50 Cr and a paid-up capital of ₹10.54 Cr.
Formerly known as Windlas Biotech Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹644.42 Cr and a net worth of ₹450.29 Cr. Employing 939 professional, Its leadership includes Hitesh Windlass (Managing Director), Pawan Kumar Sharma (Director), Manoj Kumar Windlass (Managing Director). Past directors included Hitesh Windlass, Pawan Kumar Sharma, Manish Kumar. It holds ₹73.30 Cr open charges and ₹183.40 Cr settled loans. Its latest AGM occurred on 28 July 2025, with the balance sheet filed on 31 March 2025. It is based at 40/1 Mohabewala Industrial Area, Dehradun, Uttarakhand, 248110.
L74899UR2001PLC033407
033407
19 February 2001
₹77.50 Cr
₹10.54 Cr
Roc Uttarakhand
Listed (BSE: 543329, NSE: WINDLAS)
Active
Explore comprehensive insights into Windlas Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hitesh Windlass | Managing Director | 21 Jan 2008 | Current |
| Pawan Kumar Sharma | Director | 11 Jun 2019 | Current |
| Manoj Kumar Windlass | Managing Director | 01 Apr 2006 | Current |
| Prachi Jain Windlass | Director | 03 May 2021 | Current |
| Gaurav Gulati | Director | 06 May 2021 | Current |
| Srinivasan Venkataraman | Director | 06 May 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Apr 2020 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2019 | Past |
| Pramod Abcsdd | Company Secretary | 23 Feb 2008 | Past |
| Pramod Abcsdd | Director | 21 Apr 2021 | Past |
| Pramod Abcsdd | Director | 30 Apr 2020 | Past |
| Pramod Abcsdd | Director | 15 Sep 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Windlas Biotech Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 23.21% increase. The company also saw a substantial improvement in profitability, with a 36.35% increase in profit. The company's net worth Soared by an impressive increase of 11.83%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Windlas Biotech had a promoter holding of 62.82% and a public holding of 37.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹733,000,000.00
₹1,834,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹40.00 Cr | Open |
| 04 Feb 2015 | Others | ₹10.00 Cr | Open |
| 28 Apr 2010 | Hdfc Bank Limited | ₹23.30 Cr | Open |
| 16 Apr 2021 | Others | ₹20.00 Cr | Satisfied |
| 16 Mar 2021 | Others | ₹20.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Windlas Biotech has a workforce of 939 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Windlas Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Windlas Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Windlas Biotech Limited last Annual general meeting of members was held on 28 Jul 2025 as per latest MCA records. was recorded as a recent event.
The activity Windlas Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand. was completed.
Progress on A charge registered on 13 Jul 2020 via Charge ID 100360093 with Sidbi was fully satisfied on 20 Mar 2025. was documented.
Progress on A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 40.00 Cr registered on 27 May 2022 with Charge ID 100575416 was modified on 17 Mar 2025. was documented.
The activity A charge with Hdfc Bank Limited of Rs. 23.30 Cr registered on 28 Apr 2010 with Charge ID 10223457 was modified on 08 Jan 2025. was completed.
The activity A charge with Others of Rs. 10.00 Cr registered on 04 Feb 2015 with Charge ID 10547318 was modified on 30 Apr 2024. was completed.
When you're about to exhaust your current fund but still want to make it rain, so you plan to raise a new fund of $200 million. You're also focusing on making bigger investments and lining up some sweet exits. Investors are eyeing India for its improving economy and high exit activity, but it's not all sunshine and rainbows for new funds. #FundraisingStruggles #MakingItRain #InvestingGoals #IndiaEconomy #ExitGameStrong.
The CIN of Windlas Biotech Limited is L74899UR2001PLC033407.
Windlas Biotech Limited is headquartered at 40/1 Mohabewala Industrial Area, Dehradun, Uttarakhand, 248110.
Windlas Biotech Limited was incorporated on 19 February 2001.
The current directors of Windlas Biotech Limited are
The primary industry of Windlas Biotech Limited is Manufacturing.
Windlas Biotech Limited is listed. It is listed on BSE: 543329 and NSE: WINDLAS.
The authorized capital of Windlas Biotech Limited is ₹77.50 Cr, and the paid-up capital is ₹10.54 Cr.
The compliance status of Windlas Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX